BREATH TEST FOR DISEASE DETECTION

COVID-19

Breathonix BreFence™ Go COVID-19 Breath Test System has gained Singapore  HSA Provisional Approval.

Other Fatal Diseases

Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis. 

KEY HIGHLIGHTS

Slingshot 2019 MedTech Winner

Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.

6+ Years of Breath Analysis Research

The technology is developed from 6+ years of breath analysis research in National University of Singapore (NUS).

Backed by Reputable Investors

Funded by NUS Enterprise, Origgin and Antler.

COLLABORATION

To the ones who made it possible 

JOIN OUR MISSION

Reimagine Diagnostics with Rapid Breath Test for Disease Detection

LATEST UPDATES

SINGAPORE, 16 July 2021 – Singapore-based firms Accredify and Breathonix today announced their collaboration to supply an on-site COVID-19 rapid-breath test system that issues digital verifiable COVID-19 test results compliant with countries’ international travel and domestic health requirements in less than […]
Local conglomerate Vingroup has successfully reached a deal with Singaporean firm Breathonix to bring to Vietnam a COVID-19 breath testing system costing over 460 billion VND (20 million USD). Hanoi (VNA) – Local conglomerate Vingroup has successfully reached a deal with […]
Malaysia-based government services provider MyEG Services has signed a deal with National University of Singapore spin-off Breathonix to provide a rapid breath test system for Covid-19 in Malaysia. Following the memorandum of understanding, MyEG will begin applying for regulatory approvals and certifications for the […]